Phibro Animal Health | PAHC - Cost Of Sales


Phibro Animal Health reported $240.42M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Align Technology USD 298.76M 4.74M Jun/2026
ANI Pharmaceuticals USD 119.8M 5.3M Jun/2026
Aurora Cannabis CAD 8.22M 80.38M Mar/2026
Bristol-Myers Squibb USD 7.89B 4.03B Jun/2026
Canopy Growth CAD 62.98M 9.91M Mar/2026
Corcept Therapeutics USD 4.06M 1.18M Jun/2026
Eli Lilly USD 3.27B 309M Jun/2026
Henry Schein USD 2.43B 129M Jun/2026
Idexx Laboratories USD 437.5M 19.42M Jun/2026
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Merck USD 3.14B 200M Jun/2026
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Pacira USD 58.49M 7.75M Jun/2026
Phibro Animal Health USD 240.42M 2.58M Dec/2025
Prestige Brands USD 135.22M 5.54M Jun/2026
Supernus Pharmaceuticals USD 59M 9.97M Jun/2026
Zoetis USD 704M 32M Jun/2026